Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Part of paid clinical trials in Aurora, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT06693622
Status
Recruiting
Apply to this trial

Conditions

  • Barrett Esophagus
  • Gastro Esophageal Reflux Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Accepted

Interventions

  • Patient survey — BEHAVIORAL
    To assess patient preferences and barriers for attributes of BE/EAC screening modalities patients will complete a survey evaluating 5 domains: benefit of detection (sensitivity), convenience (time, setting), screening related physical harms (procedural discomfort), and financial harms. Prior to distribution, the survey will be refined and pretested among a sample of 5 patients.

Study Details

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.

Key Dates

Start date
Nov 1, 2024
Status verified
Nov 2024
Primary completion
Mar 1, 2029
Completion
Mar 1, 2029

Study Design

Enrollment
556 participants (estimated)

Arms

  • Arm: Patients
    556 eligible patients will be recruited across 5 participating sites to complete a discrete choice-based conjoint survey. The survey will be distributed to eligible patients via Sawtooth internet survey at the time of a clinic appointment or remotely via video chat.

Primary Outcome Measure

Define patient preferred BE/EAC screening test and barriers for attributes of BE/EAC screening tests [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Colorado Anschutz Medical CampusAuroraColorado80045
Alexa DeBord, MS
[email protected]
303-724-0432
Sachin Wani, MD (PRINCIPAL_INVESTIGATOR)
Sridevi Pokala, MD (SUB_INVESTIGATOR)
Mohammad Bilal, MD (SUB_INVESTIGATOR)
Mark Earnest, MD (SUB_INVESTIGATOR)

Find similar trials in Aurora, CO

By research site
University of Colorado Anschutz Medical Campus· Aurora, CO

Related Studies